Dermatologists' Management Approach to Sexually Transmitted Disease

Main Article Content

Ted Rosen
Professor of Dermatology Baylor College of Medicine

Keywords

Abstract

Abstract not available.

References

1. World Health Organization. Report on global sexually transmitted infection surveillance 2018. Accessible at: https://www.who.int/reproductivehealth/publications/stis-surveillance-2018/en/

2. Centers for Disease Control and Prevention (CDC). Sexually transmitted disease surveillance 2018. Downloadable report accessible at: https://www.cdc.gov/std/stats18/STDSurveillance2018-full-report.pdf

3. European Centre for Disease Prevention and Control (ECDC). Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. Accessible at: https://www.ecdc.europa.eu/en/publications-data/syphilis-and-congenital-syphilis-europe-review-epidemiological-trends-2007-2018

4. Shinkai K, Bauchner H. Celebrating the 100th anniversary of JAMA Dermatology as a publication of the American Medical Association, 1920 to 2020. JAMA Dermatol. 2020 Jan 8. doi: 10.1001/jamadermatol.2019.3776.

5. Rosen T. Syphilis and the dermatologist. Cutis. 2017;100(5):279-280.

6. University of Michigan National Poll on Healthy Aging, May 2018. Sex after 65. Accessible at: https://medicine.umich.edu/dept/intmed/news/archive/201805/national-poll-healthy-aging-may-2018-report-sex-after-65

7. Centers for Disease Control and Prevention (CDC). Screening recommendations and considerations referenced in treatment guidelines and original sources. Accessible at: https://www.cdc.gov/std/tg2015/screening-recommendations.htm

8. Centers for Disease Control and Prevention (CDC). 2015 Sexually Transmitted Diseases Treatment Guidelines. Accessible at: https://www.cdc.gov/std/tg2015/default.htm

9. Shao LL, Guo R, Shi WJ, et al. Could lengthening minocycline therapy better treat early syphilis? Medicine (Baltimore).2016;95(52):e5773. doi:10.1097/MD.0000000000005773

10. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350(1):11-20.

11. Frobert E, Burrel S, Ducastelle-Lepretre S, et al. Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France. Antiviral Res. 2014;111:36-41.

12. Chilukuri S, Rosen T. Management of acyclovir-resistant herpes simplex virus. Dermatol Clin. 2003;21(2):311-20.

13. Bertolotti A, Milpied B, Fouéré S, et al. Local management of anogenital warts in immunocompetent adults: Systematic review and pooled analysis of randomized-controlled trial data. J Am Acad Dermatol. 2019;81(5):1203-1204

14. O'Mahony C, Gomberg M, Skerlev M, et al. Position statement for the diagnosis and management of anogenital warts. J Eur Acad Dermatol Venereol. 2019;33(6):1006-1019

15. Shimabukuro TT, Su JR, Marquez PL, et al. Safety of the 9-Valent Human Papillomavirus Vaccine. Pediatrics. 2019 Dec;144(6). pii: e20191791; doi: 10.1542/peds.2019-1791

16. Ortega-Loayza AG, McCall CO, Nunley JR. Crusted scabies and multiple dosages of ivermectin. J Drugs Dermatol. 2013;12(5):584-5.

17. Siegler AJ, Rosenthal EM, Sullivan PS, et al. Levels of clinical condom failure for anal sex: A randomized cross-over trial. EClinicalMedicine. 2019 Oct 31;17:100199. doi: 10.1016/j.eclinm.2019.10.012

Article Sidebar

PDF
Published
Mar 8, 2020
DOI https://doi.org/10.25251/skin.4.2.1

Article Details

How to Cite
[1]
Rosen, T. 2020. Dermatologists’ Management Approach to Sexually Transmitted Disease. SKIN The Journal of Cutaneous Medicine. 4, 2 (Mar. 2020), 102–105. DOI:https://doi.org/10.25251/skin.4.2.1.
Issue
Vol. 4 No. 2 (2020)
Section
Clinical Management Recommendations
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.